venlafaxine

FDA Drug Profile — venlafaxine, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE

Drug Details

Generic Name
venlafaxine
Brand Names
venlafaxine, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE
Application Number
ANDA078932
Sponsor
Alembic Pharmaceuticals Limited
NDC Codes
39
Dosage Forms
TABLET, TABLET, EXTENDED RELEASE
Routes
ORAL
Active Ingredients
VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE BESYLATE MONOHYDRATE

Indications and Usage

1 INDICATIONS AND USAGE Venlafaxine hydrochloride extended-release capsules are indicated in adults for the treatment of: • Major Depressive Disorder (MDD) [see Clinical Studies ( 14.1 )] • Generalized Anxiety Disorder (GAD) [see Clinical Studies ( 14.2 )] • Social Anxiety Disorder (SAD) [see Clinical Studies ( 14.3 )] • Panic Disorder (PD) [see Clinical Studies ( 14.4 )] Venlafaxine hydrochloride extended-release capsules are a serotonin and norepinephrine reuptake inhibitor (SNRI) indicated for the treatment of adults with: • Major Depressive Disorder (MDD) ( 1 ) • Generalized Anxiety Disorder (GAD) ( 1 ) • Social Anxiety Disorder (SAD) ( 1 ) • Panic Disorder (PD) ( 1 )